Request Deal Involvement

CMBI and Mirae led a $120m Series C funding round in EpimAb.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

MacDougall

pr advisors

MacDougall

or

Principals

OCTAGON INVESTMENTS

bidder

OCTAGON INVESTMENTS

SHANGBAY CAPITAL

bidder

SHANGBAY CAPITAL

ADRIAN CHENG

bidder

ADRIAN CHENG

CHINA MERCHANTS BANK

bidder

CHINA MERCHANTS BANK

DECHENG CAPITAL LLC

bidder

DECHENG CAPITAL LLC

HONY CAPITAL CO LTD

bidder

HONY CAPITAL CO LTD

SDIC FUND MANAGEMENT CO LTD

bidder

SDIC FUND MANAGEMENT CO LTD

CORMORANT ASSET MANAGEMENT

bidder

CORMORANT ASSET MANAGEMENT

SHERPA HEALTHCARE PARTNERS

bidder

SHERPA HEALTHCARE PARTNERS

EPIMAB BIOTHERAPEUTICS

target

EPIMAB BIOTHERAPEUTICS

HIDRAGON CAPITAL

bidder

HIDRAGON CAPITAL

MIRAE ASSET FINANCIAL GROUP

bidder

MIRAE ASSET FINANCIAL GROUP

YANCHUANG CAPITAL

bidder

YANCHUANG CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - CMBI and Mirae led a $120m Series C funding round in EpimAb.